The Clinical Approach Towards Chondrosarcoma

Hans Gelderblom(Leiden University Medical Center), Judith V.M.G. Bovée(Leiden University Medical Center), Sander D. Dijkstra(Leiden University Medical Center), Augustinus D. G. Krol(Leiden University Medical Center), Antonïe H.M. Taminiau(Leiden University Medical Center), Carla SP van Rijswijk(Leiden University Medical Center), Pancras C.W. Hogendoorn(Vrije Universiteit Brussel)
The Oncologist
March 1, 2008
10.1634/theoncologist.2007-0237
Cited by 738

Related Papers

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
Cremophor EL
|European Journal of Cancer|2001|1.6k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial
|The Lancet|2012|1.4k
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
|The Lancet Oncology|2014|1.2k